Molecular Imaging Market
Global Molecular Imaging Market Market: By Type (Positron Emission Tomography, Single Photon Emission Computed Tomography, Optical Bioluminescence Imaging, Optical Fluorescence Imaging, Magnetic Resonance Imaging, Computed Tomography, Ultrasound, Others,) By Type of disease, (Neurological disorders, Bone disorders, Cancer, Gastrointestinal disorders, Cardiology Disorders, Kidney Diseases, Lung Disorders, Thyroid Disorders, Others,) By Consumables, (Contrast Agents, SPECT Probes, PET Tracers, Optical Imaging Reagents), By Application, (Molecular Biology, Multiple Image Capturing, Pharmacology, Chemistry, Bioinformatics, Biomathematics, Medical Physics, Others), By End User, (Ambulatory Surgical Centers, Diagnostic Centers, Hospitals) and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2016 and Forecast 2017 to 2024
Molecular imaging is an innovative discipline in biomedical research, which facilitates visualizing, characterizing and quantifying the biological processes that takes place at cellular stage and sub cellular stages within intact living beings. The produced images from molecular imaging reflect the disease mechanisms, molecular pathways and cellular pathways of the disease that is present in the subject by in vivo and in vitro techniques.
Market Dynamics: Molecular Imaging Market
Rise in geriatric population, increase in prevalence of cardiovascular, orthopedic disorders, neurological disorders, less side effects associated with the imaging techniques, and advancements in technology like high field strength are expected to drive the growth of global molecular imaging market over the forecast period. Moreover, rise in demand for minimally invasive and non-invasive diagnostic procedures, growing awareness regarding health in developing countries, and wide range of applications of molecular imaging techniques are enables propel the growth of molecular imaging market. On the other side, high cost associated with the diagnosis, unfavorable reimbursement policies, growing competition from cost effective imaging techniques, and dearth of skilled professionals are main restraints of molecular imaging market.
Market Scope: Molecular Imaging Market
Molecular Imaging Market is segmented on the basis of type, type of disease, application, consumables, end user and geography.
Based on the type, molecular imaging market is segmented into the following
- Positron Emission Tomography
- Single Photon Emission Computed Tomography
- Optical Bioluminescence Imaging
- Optical Fluorescence Imaging
- Magnetic Resonance Imaging
- Computed Tomography
- Ultrasound
- Others
Based on the type of disease, molecular imaging market is segmented into the following
- Neurological Disorders
- Bone Disorders
- Cancer
- Gastrointestinal Disorders
- Cardiology Disorders
- Kidney Diseases
- Lung Disorders
- Thyroid Disorders
- Others
Based on the Consumables, it is segmented into the following
- Contrast Agents
- SPECT Probes
- PET Tracers
- Optical Imaging Reagents
Based on the application, it is segmented into the following
- Molecular Biology
- Multiple Image Capturing
- Pharmacology
- Chemistry
- Bioinformatics
- Biomathematics
- Medical Physics
- Others
Based on the end user, it is segmented into the following
- Ambulatory Surgical Centers
- Diagnostic Centers
- Hospitals
Market Summary: Molecular Imaging Market
Molecular imaging enables help researches to gain better understanding of basic mechanisms underlying in cancers. Information that is provided by molecular imaging is way potential in development of drugs. Molecular imaging market has a lucrative growth due to advanced technologies like introduction of innovative molecular imaging devices with high and low magnetic field strengths. Moreover, expanding applications of molecular imaging in the breast cancer screening and neurological disorders such as Alzheimer’s disease and multiple sclerosis, spine and musculoskeletal injuries are expected to boost the molecular imaging market. Furthermore, market players are adopting strategies such as acquisitions and mergers, collaborations, and launching of newer devices are upsurge the revenue of Molecular Imaging Market. For instance, in July 2012, Aurora Imaging Technology, Inc. and SUMEC Group Corporation entered into a distribution agreement for expansion of breast MRI in China and in September 2016, GE Healthcare received market clearance for MAGiC (MAGnetic resonance image Compilation) software, a multi contrast MRI technique that delivers eight contrasts in a single acquisition in fraction of time of conventional imaging.
Regional Analysis: Molecular Imaging Market
Geographically, global molecular imaging market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America Molecular Imaging Market is expected to offer enormous growth opportunities due to rise in prevalence of neurological disorders, technological advancements of devices, well developed healthcare infrastructure. Europe Molecular Imaging Market has lucrative growth owing to rise in adoption of newer technologies, increase in prevalence of chronic diseases, rise in demand for early diagnosis. Asia Pacific Molecular Imaging Market is anticipated to grow at a significant rate owing to growing medical tourism in India and China, large population pool, growing disposable income, and growing healthcare awareness. Latin America Molecular Imaging Market has a significant growth owing to rise in number of road accidents and sports injuries, adoption of newer technologies, and expansion of business by market players are expected to fuel the market. Middle East and Africa Molecular Imaging Market has a significant share owing to development in economic growth, increase in awareness about early stage disease diagnosis, and rise in prevalence of chronic diseases are boost the market.
Competition Assessment: Molecular Imaging Market
Notable players’ profiles in the global molecular imaging market include
- Hitachi Medical Corporation (Japan)
- Siemens Healthineers (Germany)
- Toshiba Medical Systems (Japan)
- GE Healthcare (UK)
- Philips Healthcare (Netherlands)
- Esaote SpA (Italy)
- Sanrad Medical Systems Pvt. Ltd (India)
- Aurora Imaging Technology, Inc. (U.S.)
- SUMEC Group Corporation (China)
- Positron Corporation (U.S.)
Notable Market Developments: Molecular Imaging Market Market
- In October 2017, Siemens Heathineers received FDA clearance for Magnetom Terra, a high field 7T MRI scanner
- In November 2014, FUJIFILM Corporation entered into Positron Emission Tomography radiopharmaceuticals used in functional diagnosis of various cancers, neurological and heart diseases.
Key Features of the Report:
- The report provides granular level information about the market size, regional market share, historic market (2013 to 2016) and forecast (2017 to 2024)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
